Encompass Health stock hits 52-week high at $123.13

Encompass Health (NYSE:EHC) Corp’s stock reached a significant milestone, hitting a 52-week high of $123.13. This achievement reflects a robust 1-year change, with the stock appreciating by 37.39%. With a market capitalization of $12.4 billion and an impressive year-to-date return of 32.91%, the healthcare provider has demonstrated strong momentum. InvestingPro analysis suggests the stock is slightly overvalued at current levels, though analysts maintain a Strong Buy consensus. The company’s performance has been notably strong over the past year, contributing to this upward trend. With revenue growth of 11.8% and a GREAT Financial Health Score from InvestingPro, Encompass Health continues to expand its services and enhance its market position. The company has maintained dividend payments for 13 consecutive years, demonstrating operational stability. Investors have shown increased confidence in the company’s strategic direction, driving the stock to its current peak. For deeper insights, access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.

In other recent news, Encompass Health Corp reported impressive financial results for the second quarter of 2025. The company exceeded expectations with earnings per share of $1.40, surpassing the anticipated $1.21, and achieved revenue of $1.46 billion against a forecast of $1.43 billion. Encompass Health and BSA Health System also announced a joint venture to operate a 50-bed inpatient rehabilitation hospital in Amarillo, Texas, which will replace BSA’s existing 24-bed unit. Additionally, Encompass Health plans to construct a new 50-bed rehabilitation hospital in Haslet, Texas, with an expected opening in 2027. Truist Securities raised its price target for Encompass Health to $140, maintaining a Buy rating, following an optimistic management meeting that highlighted strong demand trends. These developments reflect significant growth and expansion efforts by Encompass Health in the healthcare sector.

This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.